Patent ID: 6518292
Filing Date: 2003-02-11
Classification: A61P,C07D

Abstract:
A compound of formula II including pharmaceutically acceptable salts thereof, prodrug esters thereof, and all stereoisomers thereof,wherein R1 is alkyl, aryl, alkenyl, alkynyl, arylalkyl, cycloalkyl, cycloalkylalkyl, alkoxyalkyl, arylalkyloxyalkyl, aryloxyalkyl, heteroaryl, cycloalkylalkoxyalkyl, heteroarylalkyl, cycloheteroalkyl or cycloheteroalkylalkyl, and these groups may be optionally substituted by 1,2 or 3-substituents selected from halogen, â€”OR8, â€”OC(O)R8, alkyl, phenyl, phenoxy, halophenyl, â€”CF3, â€”OCF3, â€”N(R8a)C(O)(R8), or â€”N(R8) (R8a); R1a is H, alkyl, or cycloalkyl; A is oxygen, sulfur, â€”NHâ€”, â€”Nâ€”R5, or â€”NC(O)â€”R2; B is â€”CR5b or â€”Nâ€”; Z is a bond or â€”Sâ€”; R2 is alkyl, aryl, alkenyl, alkynyl, arylalkyl, cycloalkyl, cycloalkylalkyl, alkoxyalkyl, aryloxyalkyl, heteroaryl, or heteroarylalkyl, and these groups may optionally be substituted by 1,2 or 3-substituents selected from halogen, â€”OR8b, â€”OC(O)R8b, alkyl, phenyl, phenoxy, halophenyl, â€”CF3, â€”OCF3, â€”N(R8c)C(O)(R8b), or â€”N(R8c)(R8b); R3 is H, halogen, alkyl, aryl, alkenyl, alkynyl, alkaryl, alkoxy, aryloxy or J1, and where alkyl, aryl, alkenyl, alkynyl, arylalkyl, alkoxy, or aryloxy may be optionally substituted with 1 to 3 J1; R4 and R4a are the same or different and are independently selected from H, halogen, â€”CF3, alkyl, or aryl; R5 is H, alkyl, aryl, alkenyl, arylalkenyl, alkynyl, arylalkyl, arylalkynyl, cycloalkylalkyl, alkoxyalkyl, aryloxyalkyl, arylalkyloxyalkyl, heteroaryl, cycloalkylalkoxyalkyl, â€”SO2T1, â€”SO2N(T1a)T1, or heteroarylalkyl, and where alkyl, aryl, alkenyl, arylalkenyl, alkynyl, arylalkyl, arylalkynyl, cycloalkylalkyl, alkoxyalkyl, aryloxyalkyl, arylalkyloxyalkyl, heteroaryl, heteroaryloxyalkyl, cycloalkylalkoxyalkyl, or heteroarylalkyl may be independently optionally substituted with 1 to 3 J1; R5a and R5b are the same or different and are independently selected from H, alkyl, aryl, alkenyl, arylalkenyl, alkynyl, arylalkyl, arylalkynyl, cycloalkylalkyl, alkoxyalkyl, aryloxyalkyl, arylalkyloxyalkyl, heteroaryl, cycloalkylalkoxyalkyl, heteroarylalkyl, or J1, and where alkyl, aryl, alkenyl, arylalkenyl, alkynyl, arylalkyl, arylalkynyl, cycloalkylalkyl, alkoxyalkyl, aryloxyalkyl, arylalkyloxy-alkyl, heteroaryl, heteroaryloxyalkyl, cycloalkylalkoxy-alkyl, or heteroarylalkyl may be independently optionally substituted with 1 to 3 J1; Y is where x and y are independently 0 to 3 and z is 1 to 3;Xc is a bond, â€”Nâ€”R6a or â€”Oâ€”;R7 and R7a are the same or different and are independently selected from H, alkyl, â€”CF3, phenyl, aryl, arylalkyl, and cycloalkyl; or one or both of R7 and R7a can be independently joined to one or both of R9 and R10 groups (of Xb) to form an alkylene bridge of 1 to 5 carbon atoms; or R7 and R7a are joined together to form a ring of from 3-7 carbon atoms; R6, R6a, R6b, R6c, R8, R8a, R8b, R8c, R8d, R8e, R8f, R8g, R8h, R8i, R8k, R8l, and R8m are the same or different and are independently H, alkyl, cycloalkyl, alkenyl or aryl; R8j is H, alkyl, aryl, hydroxy or â€”OC(O)R8k; Xb is R9 and R10 are the same or different and are independently selected from H, alkyl, and substituted alkyl where the substituents may be 1 to 3 hydroxy, 1 to 3 C1-C10-alkanoyloxy, 1 to 3 C1-6 alkoxy, phenyl, phenoxy, C1-C6-alkoxycarbonyl; or R9 and R10 can together form â€”(CH2)tXd(CH2)uâ€” where Xd is C(R8h)(R8j), â€”Oâ€” or â€”N(R6b), t and u are independently 1-3; R11 is H, C1-C6alkyl, â€”CF3, arylalkyl, or aryl, and with the alkyl and aryl groups being optionally substituted with 1 to 3 hydroxy, 1 to 3 C1-10alkanoyloxy, 1 to 3 C1-6 alkoxy, phenyl, phenoxy or C1-C6 alkoxycarbonyl; R12 and R13 are independently H, C1-C6alkyl, â€”CF3, aryl, or halogen, and with the alkyl and aryl groups being optionally substituted with 1 to 3 hydroxy, 1 to 3 C1-C10-alkanoyloxy, 1 to 3 C1-6 alkoxy, or C1-C6 alkoxycarbonyl; J1 is nitro, â€”(CH2)vN(T1a)C(O)T1, â€”(CH2)vCN, â€”(CH2)vN(T1a)C(O)OT1, â€”(CH2)vN(T1a)C(O)N(T1b)T1, â€”(CH2)vN(T1a)SO2T1, â€”(CH2)vC(O)N(T1a)T1, â€”(CH2)vC(O)OT1, â€”(CH2)vOC(O)OT1, â€”(CH2)vOC(O)T1, â€”(CH2)vOC(O)N(T1a)T1, â€”(CH2)vN(T1a)SO2N(T1b)T1, â€”(CH2)vOT1, â€”(CH2)vSO2T1, â€”(CH2)vSO2N(T1a)T1, â€”(CH2)vC(O)T1, â€”(CH2)vCH(OH)T1, cycloheteroalkyl or heteroaryl, with v being 0-5; T1, T1a and T1b are the same or different and are independently H, alkyl, alkenyl, alkynyl, lower alkythioalkyl, alkoxyalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloheteroalkyl, or cycloalkyl, each of which may be optionally substituted with 1, 2 or 3 substituents selected from halogen, hydroxyl, â€”NR8fC(O)NR8gR8i, â€”C(O)NR8fR8g, â€”NR8fC(O)R8g, â€”CN, â€”N(R8f)SO2R14, â€”OC(O)R8f, â€”SO2NR8fR8g, â€”SOR14, â€”SO2R14, alkoxy, â€”COOH, cycloheteroalkyl, or â€”C(O)OR14; or T1 and T1a or T1 and T1b can together form â€”(CH2)wXe(CH2)zâ€” where Xe is â€”C(R8m)(R8l), â€”Oâ€”, â€”Sâ€”, â€”SOâ€”, â€”SO2â€”, â€”NC(O)OR14a, â€”NC(O)NR14aR14b, â€”NC(O)R4a or â€”N(R6c) where w and z are each independently 1-3; with the proviso that T1 can not be hydrogen when it is connected to carbonyl or sulfur, as in â€”C(O)T1 or â€”SO2T1; R14, R14a, and R14b are independently C1-C6alkyl, heteroaryl, or aryl, each optionally substituted with â€”(CH2)sOH, with s being 0-5; with the proviso that the following (1) through (3) apply to compounds of formula II (1) where one or both of R7 and R7a, and one or both of R9 and R10 form an alkylene bridge then where R5 is â€”(CH2)C(O)N(T1a)T1, then at least one of T1a and T â‰ H; or (2) where R1 is arylalkyl and R1a is H and R5 is â€”(CH2)C(O)N(T1a)T1, then T1a or T1 is other than (3) where R1 and R7 are each 2-naphthyl-CH2â€”, then R5 â‰  phenethyl; and further provided that said compound is other than the compound